These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 17213016)
1. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938 [TBL] [Abstract][Full Text] [Related]
3. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies. Sezgin O; Aydın MK; Özdemir AA; Kanık AE Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997 [TBL] [Abstract][Full Text] [Related]
4. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002]. Buzás GM; Józan J Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530 [TBL] [Abstract][Full Text] [Related]
5. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area. Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298 [TBL] [Abstract][Full Text] [Related]
8. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Gisbert JP; Calvet X Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749 [TBL] [Abstract][Full Text] [Related]
9. [Eradication of Helicobacter pylori infection in Hungary (1993-2002): a meta-analysis]. Buzás GM Orv Hetil; 2003 Jun; 144(22):1077-83. PubMed ID: 12847817 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease]. Habu Y; Kiyota K; Inokuchi H; Sugano Y; Ko K; Waki S Nihon Rinsho; 1999 Jan; 57(1):135-9. PubMed ID: 10036950 [TBL] [Abstract][Full Text] [Related]
11. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378 [TBL] [Abstract][Full Text] [Related]
12. [First line therapy for Helicobacter pylori eradication in France]. Dupas JL Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504 [TBL] [Abstract][Full Text] [Related]
13. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea. Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780 [TBL] [Abstract][Full Text] [Related]
15. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805 [TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. Palmas F; Pellicano R; Massimetti E; Berrutti M; Fagoonee S; Rizzetto M Panminerva Med; 2002 Jun; 44(2):145-7. PubMed ID: 12032434 [TBL] [Abstract][Full Text] [Related]
17. Indications for treatment of Helicobacter pylori infection: a systematic overview. Veldhuyzen van Zanten SJ; Sherman PM CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341 [TBL] [Abstract][Full Text] [Related]
18. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study]. Multiple Center Study Group In Beijing Area, China Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976 [TBL] [Abstract][Full Text] [Related]
19. My approach to Helicobacter pylori eradication. Bazzoli F Eur J Gastroenterol Hepatol; 1999 Jun; 11 Suppl 1():S37-41. PubMed ID: 10443911 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]